Browse Category

NASDAQ:TMDX 13 January 2026 - 25 February 2026

TransMedics (TMDX) stock jumps 7% premarket after earnings, 2026 revenue outlook

TransMedics (TMDX) stock jumps 7% premarket after earnings, 2026 revenue outlook

TransMedics Group shares jumped 7.3% premarket to $147.88 after posting Q4 revenue of $160.8 million, up 32%, and setting a 2026 revenue forecast of $727–$757 million. Net income for the quarter reached $105.4 million, boosted by an $83.8 million tax benefit. Adjusted earnings were 57 cents per share, topping analyst estimates. Gross margin slipped to 58% as clinical service and freight costs rose.
TransMedics stock jumps as SEC filing details $23.9 million-a-year lease for new Massachusetts HQ

TransMedics stock jumps as SEC filing details $23.9 million-a-year lease for new Massachusetts HQ

TransMedics shares rose about 8% Tuesday after the company disclosed a lease for nearly 498,000 square feet in Somerville, Massachusetts, to serve as its new global headquarters. The lease begins in early 2028 with base rent starting at $23.9 million per year and an $18 million security deposit. The stock touched $151.70 before closing at $145.68. State and local incentives could total up to $18 million if hiring targets are met.
13 January 2026
Go toTop